Jianhua Zhang

Dr. Jianhua Zhang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JZJianhua Zhang
Jianhua Zhang
SLShichao Liu
Shichao Liu
WGWenjiao Guo
Wenjiao Guo
YHYun Huang
Yun Huang
NLNa Li
Na Li
Oxyresveratrol, a natural derivative of resveratrol, has been shown to possess antimelanogenic properties. However, the underlying mechanism and its effect on melanin transfer remain poorly understood. In this study, the effects and mechanisms of oxyresveratrol on melanogenesis, dendrite formation, and melanosome transport were investigated. In vitro assays indicated that oxyresveratrol is a potent inhibitor of human tyrosinase, with an IC50 value of 2.27 µg/mL. Treatment of B16F10 melanoma cells with oxyresveratrol suppressed melanogenesis through the down-regulation of the MC1R/cAMP/MITF signaling pathway. In a co-culture model of B16F10 and HaCaT cells, oxyresveratrol inhibited both melanin transfer and dendrite formation by down-regulating the expression of small GTPases (CDC42, RAB17, RAB11B, RAC1) and the kinesin KIF5B. These findings suggested that oxyresveratrol may serve as a promising therapeutic agent for pigment-related disorders by inhibiting melanogenesis, dendrite formation, and melanosome transport.

24 September 2025 in Plants
Verified
Journal Article
Open access
PDF file
YZYali Zhang
Yali Zhang
JZJianhua Zhang
Jianhua Zhang
YWYani Wu
Yani Wu
YWYin Wu
Yin Wu
WGWenjiao Guo
Wenjiao Guo
CYChunshan You
Chunshan You
The genus Camellia offers valuable resources for tea production, oil extraction, and ornamental purposes, and its applications are expanding beyond traditional regions due to increasing human demands and advancements in research. To explore new therapeutic resources and identify key active metabolites, we conducted a non-targeted metabolomics analysis on three camellias. We also utilized network pharmacology to identify the potential targets of key metabolites involved in anti-inflammatory, antioxidant, antibacterial, and antiviral effects. A total of 385 significantly different metabolites were identified, with organic acids and derivatives, lipids and lipid-like molecules, and phenylpropanoids and polyketides being the top three metabolite classes. Of the 71 different phenylpropanoids and polyketides identified, 54 were common across all three cultivars, while 17 were unique. Network pharmacology further identified 78 potential molecular targets associated with the four therapeutic activities under study. Seven flavonoid glycosides, two flavans, two biflavonoids/polyflavonoids, and one flavone were highlighted as key active metabolites. Notably, Camellia japonica ‘Kōshi’ emerged as a promising material for future applications. The key active ingredients may contribute to the development of novel approaches for cosmetic, food, and medicinal applications, as well as germplasm innovation for new functional camellias.

1 March 2025 in Journal of Dermatologic Science and Cosmetic Technology
Verified
Journal Article
Open access
JZJianhua Zhang
Jianhua Zhang
SLShichao Liu
Shichao Liu
WGWenjiao Guo
Wenjiao Guo
ZDZhiyun Du
Zhiyun Du
LLLi Lin
Li Lin

1 February 2026 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
JZJianhua Zhang
Jianhua Zhang
SLShichao Liu
Shichao Liu
WGWenjiao Guo
Wenjiao Guo
NLNa Li
Na Li
LYLi Ye
Li Ye
Background: Intense pulsed light (IPL) therapy is widely used for skin rejuvenation but frequently induces transient skin barrier impairment, erythema, and discomfort. Post‐procedure skincare targeting barrier repair and symptom relief remains a clinical priority. Objective: To evaluate the efficacy, safety, and satisfaction of a cream containing 4‐tert‐butylcyclohexanol, Tephrosia purpurea seed extract, and Schisandra sphenanthera extract (TTS cream) in facilitating skin recovery after IPL therapy. Methods: In this randomized, double‐blind, split‐face study, 30 healthy female subjects received IPL therapy. One hemiface was randomly applied TTS cream, and the contralateral side was applied a control moisturizing toner after IPL. Objective instrument assessments were conducted at baseline (D0), post‐IPL (D0′), 30 min post‐application (D30min), and on days 3 (D3), 7 (D7), 14 (D14), and 28 (D28). Subjective assessments and satisfaction surveys were concurrently collected. Results: IPL therapy significantly increased TEWL, erythema, and skin dehydration at D0′ ( p < 0.01). At D30min, compared to the control, TTS cream significantly improved skin hydration (∆ = 12.79 vs. 0.32 C.U., p < 0.01). At D28, TTS cream significantly reduced erythema index (∆ = −54.61, p < 0.01), erythema area (∆ = −7.02%, p < 0.01), and TEWL (∆ = −4.41 g/m 2 h, p < 0.01). Subjective assessments confirmed TTS cream significantly alleviated stinging, burning, and redness ( p < 0.01). Satisfaction rates reached 100% for gentleness and 96.67% for symptom relief. No adverse effects were reported throughout the study. Conclusions: These findings indicate that the TTS cream effectively enhances skin barrier recovery, reduces erythema, and relieves discomfort following IPL therapy, highlighting its potential application in the postoperative care of aesthetic medicine.

1 June 2025 in International Journal of Dermatology
Verified
Journal Article
Closed access
JZJianhua Zhang
Jianhua Zhang
SLShichao Liu
Shichao Liu
WGWenjiao Guo
Wenjiao Guo
YHYun Huang
Yun Huang
NLNa Li
Na Li